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S U M M A R Y
Background: In France, the notiﬁcation of Legionnaires’ disease (LD) has been mandatory since 1987.
Following a study showing an important under-reporting of the disease, the surveillance system was
strengthened in 1997: the urinary antigen detection test was introduced as a new diagnostic tool and
guidelines for prevention and control of the disease were implemented. After these measures, the
incidence of LD increased gradually, reaching 2.5 per 100 000 in 2005, and then slightly decreased (2.0
per 100 000 in 2008).
Methods: Data from the mandatory notiﬁcation system and from the national reference centre for
Legionella were analysed. Analysis covered the 1998-2008 period.
Results: During the period 1998–2008 a total of 11 147 cases of LD were reported in France through the
mandatory system. Themajority of cases were diagnosed by urinary antigen test. Themedian age of cases
was 61 years, the male to female ratio was 2.9, and the case fatality rate was 13%. Exposure during travel
was documented for 17% of cases. A hospital-acquired infection was suspected for 9% of cases, and this
percentage decreased from 21% in 1998 to 7% in 2008. Over this period, 14 community outbreaks were
identiﬁed involving 380 cases, and cooling towers were the most probable source of infection for 13. No
outbreak was reported in 2008. Registration at the regional level of all cooling towers becamemandatory
at the end of 2004, and the 1997 prevention and control guidelines were updated in 2005. In recent years,
several regulations have also been implemented in the hospital setting and care homes for the elderly.
Conclusion: All these measures have contributed to strengthen the French surveillance system and
improve our ability to better prevent, detect, and control LD.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Since the ﬁrst large outbreak of pneumonia, which occurred
among American Legion members in 1976,1 awareness of the
importance of Legionnaires’ disease (LD) has consistently
increased among health professionals. LD is a severe pneumonia
contracted by inhalation of aerosols contaminated with Legio-
nella species.2 More than 50 species have been identiﬁed,3 but
Legionella pneumophila serogroup 1 (Lp1) causes the majority of
cases reported in Europe4 and in the USA.5 LD is a signiﬁcant
cause of community- and hospital-acquired pneumonia,6 and
the case fatality rate (CFR) can be as high as 30%, particularly for
hospital-acquired infections or in cases of immunosuppression.7
The majority of cases are considered to be sporadic. However,
cases related to outbreaks have enabled the identiﬁcation of* Corresponding author. Tel.: +33 1 41 79 68 90; fax: +33 1 41 79 67 69.
E-mail address: d.che@invs.sante.fr (D. Che).
1201-9712/$36.00 – see front matter  2010 International Society for Infectious Disea
doi:10.1016/j.ijid.2010.09.007speciﬁc sources of infection.8–12 Since Legionella was ﬁrst
identiﬁed,13 great advances in knowledge of the disease (clinical
presentation, risk factors, outcome), the bacteria (gene regula-
tion, virulence factors, ecology), and the environmental sources
have been made. All these elements have allowed a more
comprehensive approach to the control of the pathogen.
InFrance, theobjectivesof LDsurveillanceare tomonitor trends, to
describe cases according to their risk factors and exposure, and to
detect clustered cases or outbreaks early in order to implement
appropriate prevention and control measures. In 1996, a study
showed considerable under-reporting of the disease.14 The ﬁrst
guidelines tostrengthensurveillanceof thedisease, itspreventionand
control were drawn up in 1997 by the French health authorities. In
parallel, theurinaryantigendetection test,whichprovidesa rapidand
non-invasive diagnosis of Lp1 infection, was also introduced in 1997.
More than 10 000 cases have been reported in France since
1998. We describe here the LD trends in France, the characteristics
of patients registered in the system from 1998 to 2008, and the
implementation of adapted regulations.ses. Published by Elsevier Ltd. All rights reserved.
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2.1. The LD surveillance system
In France, the mandatory notiﬁcation of LD cases, which was
implemented in 1987, is based on a case reporting form that
collects the following information: sociodemographic data (age,
gender, area of residence), clinical data (date of symptom onset,
date of hospitalization, chest X-ray conﬁrmation of the pneumonia,
patient outcome), bacteriological data (diagnosis technique,
species and serogroup), and risk factors for contracting the disease
(tobacco smoking, diabetes, or any immunosuppressive condition
such as cancer or hematological disorders or any condition
necessitating steroid therapy). Hospitalization status of patients
with date of hospitalization has been recorded since 2005.
Exposure to any of the following settings during the 10-day
period preceding symptom onset (i.e., the incubation period) is
also recorded: hospital, thermal centre, whirlpool spa, campsite,
hotel, care home for the elderly, and workplace.
Information is initially collected by the clinician or the biologist
in charge of the patient, who sends the reporting form to the
district health authority (Direction De´partementale des Affaires
Sanitaires et Sociales, DDASS) in accordance with national ethics
guidance. The DDASS is in charge of the rapid implementation of
epidemiological and environmental investigations. Cases (or their
relatives) are systematically interviewed by the DDASS using a
standardized questionnaire. The objectives are to assess risk
factors for contracting LD, to identify a possible source of exposure,
and to detect other LD cases potentially related to a common
source. If necessary, the DDASS environmental team investigates
the potential sources of contamination and collects water samples
for laboratory analysis. The notiﬁcation form is sent by the DDASS
to the national level (Institut de Veille Sanitaire, InVS), which
monitors trends, documents the epidemiological characteristics of
LD patients, and detects clustered cases that are not identiﬁed at
the local level, especially when cases exposed to a common source
are reported by different districts (or different countries).
The national reference centre for Legionella (NRC-L) plays a key
role in the epidemiological surveillance of LD, through the
conﬁrmation of uncertain cases and the molecular typing of
isolates. When a sample is taken or a Legionella strain is isolated,
the sample or isolate is sent to the NRC-L for characterization and
molecular analysis. The NRC-L reports all results to InVS and to the
corresponding DDASS.
Hotels, campsites, and other travel-related accommodation are
recognized to be high-risk settings for LD.15 Exposure to these
settings is monitored through the EWGLI network (European
Working Group for Legionella Infections), a network of 36
participating countries that has included France since 199716 (in
April 2010, the EWGLI network moved to ECDC, Stockholm, and
has been renamed the European Legionnaires Disease Surveillance
Network – ELDSNet). Any LD case in whom contamination may
have occurred at one of the above accommodation sites is reported
to EWGLINET, who in turn informs the country where the case has
stayed during the 10-day exposure period. A cluster, deﬁned as two
or more LD cases in the same setting within a 2-year period,
implies a systematic environmental investigation, in accordance
with the 2002 EWGLINET recommendations (http://www.ew-
gli.org). In addition, EWGLINET collects annual data on all LD
(travel- and non-travel-related) cases from participating countries
in order to monitor trends at the European level.
2.2. Milestones in national regulations and guidelines
In France, the ﬁrst guidelines on surveillance and prevention of
Legionella infection were introduced in 1997 by the Ministry ofHealth. In 1998, speciﬁc regulations related to the control and the
surveillance of the water networks were implemented in
healthcare facilities. As the number of cases was increasing and
several outbreaks had occurred, new regulations were issued
regarding the strict monitoring and control of cooling towers: in
2003 for the cooling towers in hospitals and in 2004, in
collaboration with the Ministry of the Environment, these rules
were extended to all wet cooling towers. Their registration at the
regional level was also made mandatory. Then, in 2005, the
existing guidelines for investigation and surveillance were
extensively updated. The objective was to standardize all
procedures from the detection of cases to the implementation of
control measures. These revised and comprehensive guidelines
provide additional guidance on investigation and surveillance in
care homes for the elderly. Finally, in 2006, regulations on the
organization of the response to outbreaks were issued (http://
www.sante.fr/).
2.3. Case deﬁnitions
A conﬁrmed case of Legionnaires’ disease is a patient presenting
clinical and/or radiological signs of pneumonia associated with at
least one of the following laboratory criteria: (1) isolation of
Legionella species from a culture of bronchopulmonary secretions,
or (2) a four-fold increase in antibody titers for any Legionella
specieswith a second titer1:128, or (3) a positive urinary antigen
test. A presumptive case is a patient presenting clinical and/or
radiological signs of pneumonia associated with a single elevated
antibody titer 1:256.
In healthcare settings (hospital, care home for the elderly), a
deﬁnite healthcare-associated case is an LD case that occurred in a
patient continuously hospitalized during the 10-day period prior
to symptom onset. If hospitalization has not been continuous, the
case is considered as a probable healthcare-associated case.
A travel-associated cluster is deﬁned by two or more cases who
stayed at or visited the same accommodation site in the 2–10 days
before symptom onset and whose symptom onset was within the
same 2-year period.
An outbreak is deﬁned as the occurrence of at least 10 cases of
LD who are linked in terms of time and place and may involve a
common source of contamination.
2.4. Characterization of Legionella strains
Comparisons of genomic proﬁles from clinical and environ-
mental isolates are performed by pulsed-ﬁeld gel electrophoresis
(PFGE) according to standard procedures.17 Since 2008, two
additional methods have routinely been used: sequence-based
typing (SBT)18,19 and Dresden monoclonal antibody (MAb)
subgrouping.20 Typing of clinical Legionella isolates by PFGE and
SBT in combination with epidemiological data has identiﬁed
several epidemiological groups that are used to classify clinical
strains: (1) sporadic strains are deﬁned as isolates with non-
previously identiﬁed genotype and that are epidemiologically not
linked; (2) epidemic strains share a genotype speciﬁc to an
identiﬁed outbreak; (3) endemic isolates, which also share a
previously observed genotype and are responsible for at least 30
epidemiologically unrelated cases of legionellosis. Isolates sharing
a previously identiﬁed genotype but which are non-endemic are
classiﬁed as ‘known strains’.
2.5. Data analysis
We indirectly estimated the incidence rate by calculating the
notiﬁcation rate using population estimates from the 1999
national census as the denominators. Crude and age-speciﬁc
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Figure 1. Incidence rate of Legionnaires’ disease and number of cases in France,
1988–2008.
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Figure 3. Incidence rate (per 100 000 population) of Legionnaires’ disease cases by
gender and age, France, 1998–2008.
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cases and the corresponding population estimates. We considered
age over 70 years as an additional risk factor for acquiring LD, as
published elsewhere.7 Regarding the geographic distribution of
cases, we restricted the analysis to the period 2002–2008. This was
to ensure that the widespread use of the urinary antigen test across
the country had been achieved, thus reducing the variability due to
different diagnostic procedures by region and limiting the impact of
the changing sensitivity of the surveillance system.
Data were analyzed using Epi Info software (US Centers for
Disease Control and Prevention, Atlanta, GA, USA). Comparisons
between groups were performed using Fisher’s exact test or the
Student’s t-test whenever appropriate, with a p-value of <0.05
considered as statistically signiﬁcant.
3. Results
3.1. Incidence and trends
From1998 to 2008, a total of 11 147 cases of LDwere reported in
France, corresponding to a yearly average incidence rate of 1.6 per
100 000 population. Between 1998 and 2005, the incidence rate
increased by an average of 20% per year, reaching 2.5 per 100 000 in
2005; it has since slightly decreased (2.0 per 100 000 in 2008)
(Figure 1).
3.2. Case characteristics
During the study period, 50% of cases were identiﬁed during the
four summermonths from June to September (Figure 2). The male
to female ratio was 2.9 and incidence rates inmales exceeded rates
in females for all age groups. The median age of cases was 61 years
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Figure 2. Monthly distribution of Legionnaires’ dise(range 0–103 years) and it differed by gender: 59 years (range 0–
100 years) in males and 68 years (range 3–103 years) in females.
Incidence increased with age, from 0.1 cases per 100 000 persons/
year among people aged below 30 years to 5.1 cases per 100 000
persons/year among people aged 80 years and above. Less than
0.1% of all cases were reported among children aged less than 15
years. The sex ratio and the distribution of cases by age group
remained stable over the study period. As shown in Figure 3, the
incidence rate increased with age in both genders.
Among the 11 147 reported cases, 7834 (70%) presented at least
one known risk factor for contracting LD, and in most cases a
combination of several risk factors was reported. Tobacco smoking
was the leading risk factor, reported in 6396 (57%) patients. Diabetes
was reported in 1433 (13%) cases, cancer in 1123 (10%) cases, and
immunosuppressive conditions in1068 (10%) cases.Other risk factors
including chronic respiratory or cardiac diseases, HIV infection or
alcoholism were reported in 2181 (20%) cases. Finally, 3776 (34%)
cases were older than 70 years, and among them, 42% had no known
risk factors (vs. 22% in cases aged 70 years; p< 106).
3.3. Outcome
The outcome was known for 9307 (84%) cases. The CFR was 13%
(1237/9307) over the study period. It decreased from 22% in 1998 to
11% in 2008 (p< 106) and did not signiﬁcantly differ by gender. LD
patientswhodiedwereolder thanthosewhorecovered(70.4yearsvs.
60.2years;p< 106)andtheir infectionsweremoreoftenhealthcare-
associated (20.5% vs. 6.7%; p< 106). Among the 1537 conﬁrmed
cases aged 70 years without known risk factors, the CFR was 5.1%.
Since 2006, 93 out of 4102 cases for whom data were available
(2%) did not require hospitalization. These cases were younger03 2004 2005 2006 2007 2008
ase cases by date of onset, France, 1998–2008.
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Figure 4. Isolates of Legionnaires’ disease cases by epidemiological group, France,
1998–2008.
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only one patient died (CFR = 1.1%). No other differences regarding
risk factors were noted.
3.4. Diagnostic tests
Among the 11 147 cases during this 11-year period, the great
majority were conﬁrmed cases (93%) according to our case
deﬁnition, and 9417 cases (84%) were diagnosed by a positive
urinary antigen test. The distribution of diagnostic techniques used
for conﬁrmation evolved over timewith an increasing proportion of
urinary antigen testing (39% in 1998 vs. 95% in 2008; p< 106). The
remainingLDcaseswerediagnosedeitherbyculture (3%)orbyother
techniques (serology, PCR, direct ﬂuorescent antibody staining;
13%). The species was available for 10 763 cases (97%). Themajority
of cases (88%)were due to L. pneumophila serogroup 1. Isolateswere
available for 1983 (18%) cases and this percentage remained stable
over the study period. Among these isolates, 1940 (98%) were of the
L. pneumophila species and 1844 (93%) of serogroup 1.
3.5. Strains
The NRC-L received 1916 isolates for further identiﬁcation and
molecular typing. The proportion of previously identiﬁed strains
(endemic and other) has increased in recent years (Figure 4).
Endemic strains represented 29% and 34% of all isolates in 2007 and
2008, respectively. The diversity of endemic strains increased
between 1998 and 2008 and ﬁve major endemic strains were
characterized in 2008. Among these, Paris clone isolates were
detected in 9% of culture-proven cases (164/1916; 42% were
healthcare-associated and 58% were community-acquired). The
Paris clonegroupedwithsequence type (ST) 1orST1-related isolates
with a speciﬁc PFGE pattern and different MAb subgroups:Table 1
Evolution of risk exposures of Legionnaires’ disease cases in France, 1998–2008
1998
(n=381),
%
1999
(n=440),
%
2000
(n=610),
%
2001
(n=807),
%
2002
(n=1021),
%
Hospital-acquired 21 17 20 13 10
Acquired in care home
for the elderly
– – – 2 3
Travel-associated 16 15 12 17 17
Community-acquired,
conﬁrmed and
assumed
63 68 68 70 73Philadelphia (MAb 3/1-positive), or France/Allentown (MAb 3/1-
positive), or Olda (MAb 3/1-negative). The Lorraine strain was
isolated anecdotally before 2002 (three isolates). Since 2002, the
prevalenceof this strainhas increasedconsiderably and it accounted
for 11% (23/202) of clinical isolates in France in 2008. All Lorraine
clone isolates analyzed were ST47 and MAb France/Allentown. The
most prevalent ST in culture-conﬁrmed cases was ST23. In 2008,
isolates of ST23were cultured in 40 of the 197 culture-proven cases
(20%). None of these were hospital-acquired cases.
3.6. Delays in notiﬁcation
As one of the aims of surveillance is the early implementation of
prevention and control measures, efforts were also put towards
improving delays in case reporting. The median delay between
symptom onset and notiﬁcation to the DDASS decreased from 28
days in 1998 to less than 7 days in 2006. As a consequence, the
proportion of cases reported within one incubation period (i.e., 10
days) rose from 9% in 1998 to 73% in 2008 and the proportion of
cases reported within two incubation periods (20 days) rose from
33% to 91% between 1998 and 2008. From 2005, the median delay
between the date of hospitalization and the date of notiﬁcation
was 3 days for cases diagnosed by positive urinary antigen test.
3.7. Geographic distribution
From 2002 to 2008, the average annual incidence rate of LDwas
2.1 per 100 000 population in France. Cases were reported from all
22 administrative regions, but a west–east gradient in the
incidence rates over the study period was noticed (Figure 5).
3.8. Exposure
The distribution of exposures among the 11 147 cases was:
7820 (70%) community-acquired conﬁrmed, 1921 (17%) travel-
related, 1002 (9%) hospital-acquired, and 404 (4%) acquired in a
care home for the elderly.
The percentage of hospital-acquired cases decreased over the
11-year period from 21% in 1998 to 7% in 2008 (p < 105) (Table 1).
The dates of hospitalization and onset were available for 89%
(n = 890) of cases. Among them, 39% (n = 345) were deﬁnite
healthcare-associated LD cases. Since 2001, information concern-
ing care homes for the elderly shows that about 5% of annual LD
cases live in such residences.
From 1998 to 2008, an exposure during travel was documented
for 17% (n = 1921) of cases. Among them, 65% (n = 1250) were
notiﬁed to EWGLINET, with 65% (n = 815) of cases having traveled
within France. The remaining 671 travel-associated Legionnaires’
disease (TALD) cases had stayed in private accommodation or had
not been notiﬁed to EWGLINET because their places or dates of stay
were not correctly reported. EWGLINET also notiﬁed InVS of 362
cases. These cases were diagnosed in other countries and had
traveled in France during the incubation period. Between 2002 and2003
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Figure 5. Distribution of incidence rates of Legionnaires’ disease by region in France, 2002–2008.
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occurred. Water samples were collected in 122 sites for
identiﬁcation of Legionella. Among these, 42% were negative,
17% had Legionella titers <1000 CFU/l, and for 41%, the level was
1000 CFU/l. At eight sites the clinical and environmental isolates
shared identical PFGE proﬁles.
3.9. Outbreak investigations11,21–28
From 1998 to 2008, we identiﬁed 14 community outbreaks
involving 380 (3%) cases. No outbreak was identiﬁed in 2008. The
ﬁrst outbreak was identiﬁed by EWGLINET during the Football
World Cup in Paris in 1998. It involved 20 cases, amongwhomnine
were European tourists, and the investigation showed that one
cooling tower was the source of contamination.25 The second
outbreak involved 20 cases and was identiﬁed in 2000 by the NRC-
L, who characterized seven isolates with a unique and identical
PFGE pattern (unpublished data). Other outbreaks were detected
by the local health authorities. The median number of cases per
outbreak was 22 (range 11–86), and only one outbreak involved
more than 40 cases.11 The median duration of outbreaks was 44
days (range 10–106). Twelve (86%) outbreaks took place between
May and September. During these 14 outbreaks, 5% (19/380) of
cases were not hospitalized; in particular 21% of cases were not
hospitalized during one outbreak that took place in Lyon in 2005.28The global CFR was 12.6%, and in four outbreaks, no patient died.
Cooling towers were the most probable source of infection for 13
outbreaks. These sources were conﬁrmed by epidemiological and
microbiological evidence in eight outbreaks, andwere suspected in
ﬁve. The largest outbreak occurred in the north of France during
the winter 2003–2004 with 86 conﬁrmed cases and 18 deaths. The
investigation of this outbreak showed that the aerosol spread from
the cooling towers could extend tomore than 6 km.11 In September
2006, an outbreak was suspected to be related to a whirlpool spa
display at a fair.27
4. Discussion
This analysis of the surveillance data has enabled us to describe
the epidemiology of LD and recent trends in France. We found that
there was a gradual increase in incidence until 2005 then a steady
decrease. The various steps in strengthening our surveillance
system, including the introduction of the urinary antigen test in
1997 and improvements in data quality and delays in notiﬁcation
have certainly enhanced our ability to detect, prevent, and control
LD, probably leading to the recent fall in notiﬁed cases. Since 1998,
the delay in notiﬁcation has decreased and most cases are now
notiﬁed very quickly. A shortened notiﬁcation delay in addition to
the systematic investigation of cases at the district level, has
contributed to the timely detection of clusters and outbreaks and
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All this progress was facilitated by the 2005 guidelines, which
aimed to standardize all procedures from the detection of cases to
the implementation of control measures.
Considering the aforementioned improvements and the in-
creasing sensitivity over time,29 we consider that at present, our
surveillance system enables us to provide a representative
description of the epidemiology of LD in France. Nevertheless, in
our experience of outbreak management, additional cases that
would not have been diagnosed under normal circumstances were
identiﬁed, suggesting that LD is probably still under-diagnosed and
under-notiﬁed. However, from 1998 to 2008 the incidence in
France remained higher than that in Europe (0.5 to 2.0 per 100 000
from 1998 to 2008 in France vs. 0.43 to 1.2 per 100 000 in Europe;
http://www.ewgli.org). This observation may be linked to differ-
ences in surveillance sensitivity.29,30 The national guidelines and
legislation for registeringwet cooling systems and controlling their
levels of bacteria also differ between countries.31 The potential
impact of exposure density and other environmental factors that
can play a role in the development of LD should also be considered.
For example, the UK and the Netherlands experienced an
unexplained increase in non-TALD cases during the summer of
2006.32 This suggests that notiﬁcation rates are inﬂuenced by
many factors, such as practitioner awareness, sensitivity of the
surveillance system, impact of legislation for controlling the
development of the bacteria in the aquatic environment, and
environmental factors. Therefore we must be very cautious when
discussing the differences across countries.
Considering the case characteristics, our observations were
similar to those at the European level, especially regarding the high
proportion of cases among elderly males. Advanced age and male
gender are well recognized as risk factors for LD, thus facilitating
the diagnosis among these groups. Knowledge of case character-
istics has also allowed the implementation of speciﬁc regulations
aimed at reducing the risk, e.g., in care homes for the elderly in
France in 2005. To a much lesser extent, LD can also affect
children,33 but the proportion of pediatric cases in our surveillance
data is very small, similar to observations in the USA.33,34 It is
difﬁcult to establish whether children do not develop LD or
whether children with pneumonia are not tested for LD, leading to
misdiagnosis and underreporting of pediatric cases.
Other risk factors for acquiring LD have been widely docu-
mented15,35,36 and our results conﬁrm that smoking, chronic
disorders, and cancer are frequently reported.
Case outcome was well documented in our dataset and the CFR
decreased signiﬁcantly over time. Even if we cannot differentiate
between deaths attributable to LD or an underlying disease, this
encouraging result is probably due to earlier diagnosis by urinary
antigen testing, which has contributed to reduce mortality37–39
through the prompt initiation of appropriate therapy. It has been
shown that delays in appropriate antibiotic treatment have a
negative impact on outcome40,41 and that the rapid recognition of
the disease, particularly for patients with underlying conditions, is
crucial. In order to further reduce the CFR, practitioners should be
better informed of the need to systematically use the urinary
antigen test for at-risk patients presenting clinical signs of atypical
pneumonia.
Nevertheless, the CFR is higher in France than that observed in
Europe.4 The outcome of LD cases is known for the majority of
cases in France, through the LD routine surveillance scheme. A
surveillance system enabling such a follow-up does not exist in all
other European countries.
Most cases in our data were due to Lp1 and were diagnosed by
urinary test. However, this test is speciﬁc to Lp1. The diagnosis of
LD caused by other serogroups or other species can be made by
culture from bronchopulmonary aspirations or secretions andserology, but results are not rapidly available. In accordance with
the EWGLI case deﬁnitions, diagnosis by polymerase chain reaction
(PCR) performed on respiratory samples will soon be introduced to
our case deﬁnition. This will probably facilitate the diagnosis of LD
for patients presenting clinical signs suggesting LD, but with a
negative urinary antigen test. In addition, this may contribute to
the identiﬁcation of emerging strains that can cause infections,
such as non-pneumophila Legionella.
Strain isolation allows the identiﬁcation of the source of
infection bymatching of environmental and clinical strain proﬁles.
Despite the wide-scale use of the urinary tests, cultures were
regularly carried out, as shown by the stable percentage of isolates
recovered during the study period. In fact, in France, it is
recommended that cultures be performed on pulmonary samples
for all cases with a positive urinary test, and clinicians are regularly
reminded of this recommendation. This pro-active attitude has
probably contributed to enlarge the isolate strain collection
available at the NRC-L. Since January 2008, all clinical isolates
have been routinely characterized by three different typing
methods in order to improve the discriminatory capacity. This
systematic characterization of strains, associated with available
epidemiological and sometimes environmental data, provides a
unique opportunity to develop research studies on speciﬁc strains.
For instance, Ginevra et al. showed that the Lp1 Paris strain was
associated with female sex, steroid therapy, and history of cancer
or hematological disease, whereas the Lp1 Lorraine strain was
associated with smoking.42 We emphasize that the availability of
isolates contributes to the microbiological progress towards a
better understanding of the virulence factors,43,44 the ability of
Legionella to multiply in host cells,45 and the relationship between
host characteristics and clinical presentation of the disease.
Despite the decreased percentage of hospital-acquired cases
during the study period, the number of hospital-acquired cases
remained stable. Intensive efforts to better assess and control the
risk have beenmade in healthcare facilities and care homes for the
elderly, especially with the introduction of new regulations for
prevention and control in 2002 and 2005. Hospital-acquired cases
highlight the difﬁculty in eradicating Legionella from complex
water systems despite regular maintenance and monitoring.46,47
For better prevention, the environmental long-term monitoring of
the water distribution systems appears necessary in such settings.
The percentage of TALD cases has not decreased over the years,
suggesting that travel is still an important risk factor for LD.15,36
The majority of TALD cases were in French persons traveling in
France, contrary to the northern European countries where the
majority of TALD cases have traveled abroad.16,48 EWGLINET single
case notiﬁcation does not require a systematic environmental
investigation. The local health authority is only asked to inform the
accommodation manager about the LD risk and to give advice on
sampling. For clusters, the investigations showed that amajority of
sites reported a Legionella contamination of their water networks,
but microbiological evidence of the source of contamination was
found for only eight clusters out of 123. The percentage of
contaminated accommodation sites is similar to that reported in
Italy,49 where a large number of TALD cases are also registered. In
2008, speciﬁc guidelines on LD risk were distributed to managers
of French tourist accommodation to encourage efforts aimed at
implementing prevention and control measures. In addition, in
2010, the Ministry of Health introduced new regulations requiring
a systematic water network risk assessment and a yearly water
sampling in order to reduce the number of TALD cases.
From 1998 to 2008, several community outbreaks of LD
occurred in France, most often associated with wet cooling
systems. One year after the outbreak that occurred in the north
of France,11 new regulations for cooling systems were introduced
(end 2004) to reduce the environmental risks linked to aerosol-
C. Campese et al. / International Journal of Infectious Diseases 15 (2011) e30–e37e36generating devices. These new regulations require the registration
of all wet cooling systems at the local and regional level, with
regular microbiological monitoring and inspection at least every 2
years to ensure that adequate procedures are in place. This
outbreak generated considerable media attention, which probably
contributed, at least in part, to the rapid introduction of the French
legislation. In parallel, awareness and the strong commitment of
the public health authorities have undoubtedly played an essential
role in improving the identiﬁcation of cases and outbreak
management. Of note, only one outbreak was identiﬁed during
the last 2 years. This result is very encouraging, and further efforts
to maintain the high quality of our surveillance system and our
ability to rapidly investigate and control a source of contamination
should be made.
Geographic variation in LD incidence rates was observed. This
could partly be explained by climate and meteorological condi-
tions, as recently suggested for other acute respiratory tract
infections.50 Humidity and temperature might have an inﬂuence
on LD incidence,51–54 but further studies are needed to better
understand the impact of these environmental conditions. We
know that free-living amoebae could play an important role in the
development of Legionella. Ecological studies should be encour-
aged to better understand the association between exposure
density, environmental conditions, and LD incidence.55,56
In recent years, research on Legionella has been widely
developed. New ﬁndings are especially interesting because they
are beginning to suggest associations between host factors,
Legionella genomic factors, and environmental factors that
inﬂuence the occurrence of this disease. If in future years the
research continues to progress, it may be possible, particularly in
the context of an environmental contamination, to establish if the
environmental strain could result in human cases and to identify
the populations particularly at risk. At this stage, it is still too early
to measure the possible impact of recent research on the
epidemiology of Legionnaires’ disease, but risk assessment for
human infection appears more than ever an objective to reach.
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